RMAKAL
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 May 2017)
What this means for you
This application is over — abandoned 15 May 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86400220
- Mark type
- Stylized text
- Filed
- 19 Sept 2014
- Published for opposition
- 17 Feb 2015
- Abandoned
- 15 May 2017
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical products to treat and prevent bone disease and bone conditions in the nature of osteoporosis, osteopenia, osteoarthritis, vertebral fragility fractures, bone pain due to malignancy and phantom limb pain
Owner
- Tarsa Therapeutics, Inc., Philadelphia, PA, US
- Tarsa Therapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 15 May 2017 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 15 May 2017 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Oct 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Oct 2016 — SOU EXTENSION 3 GRANTED
- 13 Sept 2016 — SOU EXTENSION 3 FILED
- 13 Sept 2016 — SOU TEAS EXTENSION RECEIVED
- 08 Apr 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Apr 2016 — SOU EXTENSION 2 GRANTED
- 03 Mar 2016 — SOU EXTENSION 2 FILED
- 06 Apr 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Mar 2016 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2015 — SOU EXTENSION 1 GRANTED
- 01 Oct 2015 — SOU EXTENSION 1 FILED
- 06 Oct 2015 — CASE ASSIGNED TO INTENT TO USE PARALEGAL